Does the bio Pharma setting of ADOBE SIGN follow other countries requirement as well as 21 CFR 11?
Hi community members,
Could someone please tell me if the Adobe sign biopharma setting meets the local requirements in countries other than US?
I know Adobe says it is compliant with 21 CFR Part 11 as stated in the link below, however couldn't found about other countries regulations.
Especially I would like to know about ER/ES guideline in Japan.
https://helpx.adobe.com/sign/using/bio-pharma-settings-configuration.html
Regards,
Soichiro
